Ferumoxides-enhanced double-echo T2-weighted MR imaging in differentiating metastases from nonsolid benign lesions of the liver

Radiology

Volumn 225, Issue 1, 2002, Pages 151-158

  Arbab, Ali S ^a   Ichikawa, Tomoaki ^a   Sou, Hironobu ^a   Araki, Tsutomu ^a   Nakajima, Hiroto ^a   Ishigame, Keiichi ^a   Yoshikawa, Takeharu ^a   Kumagai, Hiroshi ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Contrast enhancement; Cysts; Hemangioma; Liver; Liver neoplasms; Magnetic resonance (MR); Metastases

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HEMANGIOMA; HUMAN; LIVER CYST; LIVER TUMOR; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

EID: 0036788354     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2251011090     Document Type: Article

References (28)

1. Stark DD, Weissleder R, Elizondo G, et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology 1988; 168: 297-301.
2. Weissleder R, Hahn PF, Stark DD, et al. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. Radiology 1988; 169:399-403.
3. Oudkerk M, van den Heuvel AG, Wielopolski PA, Schmitz PI, Borel Rinkes IH, Wiggers T. Hepatic lesions: detection with ferumoxides-enhanced T1-weighted MR imaging. Radiology 1997; 203:449-456.
4. Seneterre E, Taourel P, Bouvier Y, et al. Detection of hepatic metastases: ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200:785-792.
5. Ros PR, Freeny PC, Harms SE, et al. Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions. Radiology 1995; 196:481-488.
6. Lencioni R, Donati F, Cioni D, Paolicchi A, Cicorelli A, Bartolozzi C. Detection of colorectal liver metastases: prospective comparison of pre- and postcontrast magnetic resonance imaging at 1.5 T, dualphase spiral CT, and spiral CT during arterial portography. MAGMA 1998; 7:76-87.
7. Strotzer M, Gmeinwieser J, Schmidt J, et al. Diagnosis of liver metastases from colorectal adenocarcinoma: comparison of spiral-CTAP combined with intravenous contrast-enhanced spiral-CT and SPIO-enhanced MR combined with plain MR imaging. Acta Radiol 1997; 38:986-992.
8. Semelka RC, Schlund JF, Molina PL, et al. Malignant liver lesions: comparison of spiral CT arterial portography and MR imaging for diagnostic accuracy, cost, and effect on patient management. J Magn Reson Imaging 1996; 6:39-43.
9. Choi D, Kim S, Lim J, et al. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus combined helical CT during arterial portography and CT hepatic arteriography. AJR Am J Roentgenol 2001; 176:475-482.
10. Ohtomo K, Itai Y, Yoshikawa K, et al. Hepatic tumors: dynamic MR imaging. Radiology 1987; 163:27-31.
11. van Beers B, Demeure R, Pringot J, et al. Dynamic spin-echo imaging with Gd-DTPA: value in the differentiation of hepatic tumors. AJR Am J Roentgenol 1990; 154:515-519.
12. Mano I, Yoshida H, Nakabayashi K, Yashiro N, Iio M. Fast spin echo imaging with suspended respiration: gadoliniumenhanced MR imaging of liver tumors. J Comput Assist Tomogr 1987; 11:73-80.
13. Murakami T, Mitani T, Nakamura H, et al. Differentiation between hepatoma and hemangioma with inversion-recovery snapshot FLASH MRI and Gd-DTPA. J Comput Assist Tomogr 1992; 16:198-205.
14. Schmiedl U, Kolbel G, Hess CF, Klose U, Kurt B. Dynamic sequential MR imaging of focal liver lesions: initial experience in 22 patients at 1.5 T. J Comput Assist Tomogr 1990; 14:600-607.
15. Ichikawa T, Arbab AS, Araki T, et al. Perfusion MR imaging with a superparamagnetic iron oxide using T2-weighted and susceptibility-sensitive echoplanar sequences: evaluation of tumor vascularity in hepatocellular carcinoma. AJR Am J Roentgenol 1999; 173:207-213.
16. Arbab AS, Ichikawa T, Araki T, et al. Detection of hepatocellular carcinoma and its metastases with various pulse sequences using superparamagnetic iron oxide (SHU-555-A). Abdom Imaging 2000; 25:151-158.
17. Reimer P, Jahnke N, Feibich M, et al. Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis. Radiology 2000; 217:152-158.
18. McFarland EG, Mayo-Smith WW, Saini S, Hahn PF, Goldberg MA, Lee MJ. Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 1994; 193:43-47.
19. Kanematsu M, Hoshi H, Murakami T, et al. Focal hepatic lesion detection: comparison of four T2-weighted MR imaging pulse sequences. Radiology 1998; 206:167-175.
20. Fenlon HM, Tello R, deCarvalho VL, Yucel EK. Signal characteristics of focal liver lesions on double echo T2-weighted conventional spin echo MRI: observer performance versus quantitative measurements of T2 relaxation times. J Comput Assist Tomogr 2000; 24:204-211.
21. Bluemke DA, Paulson EK, Choti MA, DeSena S, Clavien PA. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides-enhanced MR imaging and dual-phase helical CT. AJR Am J Roentgenol 2000; 175:1653-1658.
22. Metz CE. ROC methodology in radiologic imaging. Invest Radiol 1986; 21: 720-733.
23. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
24. Dorfman DD, Berbaum KS, Metz CE. Receiver operating characteristics rating analysis: generalization of the population of readers and patients with the jackknife method. Invest Radiol 1992; 27:723-731.
25. Ito K, Mitchell DG, Outwater EK, Szklaruk J, Sadek AG. Hepatic lesions: discrimination of nonsolid, benign lesions from solid, malignant lesions with heavily T2-weighted fast spin echo MR imaging. Radiology 1997; 204:729-737.
26. Ohtomo K, Itai Y, Furui S, Yashiro N, Yoshikawa K, Iio M. Hepatic tumors; differentiation by transverse relaxation time (T2) of magnetic resonance imaging. Radiology 1985; 155;421-423.
27. Ohtomo K, Itai Y, Yoshida H, Kokubo T, Yoshikawa K, Ilo M. MR differentiation of hepatocellular carcinoma from cavernous hemangioma: complementary roles of FLASH and T2 values. AJR Am J Roentgenol 1989; 152:505-507.
28. Grangier C, Tournaire J, Mentha G, et al. Enhancement of hepatic hemangioma on T1-weighted MR SE images by superparamagnetic iron oxide particles. J Comp Assist Tomogr 1994; 18:888-896.